Presage Biosciences Announces First Patient in Clinical Trial of CIVO™ Precision Oncology
4/22/2013 9:44:16 AM
More...
|
Presage Biosciences Snags $13 Million From Celgene Corporation (CELG) to Pick Winning Cancer Drug Combos
3/5/2013 7:49:40 AM
More...
|
Presage Biosciences and Millennium: The Takeda Oncology Company Enter Into Cancer Research Agreement
4/6/2012 9:16:29 AM
More...
|